| Dr Manisha Agarwala, MD | |
|
11700 N Meridian St, Carmel, IN 46032-4656 | |
| (317) 688-3140 | |
| (317) 688-2664 |
| Full Name | Dr Manisha Agarwala |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 11700 N Meridian St, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639325608 | NPI | - | NPPES |
| 000000741465 | Other | IN | ANTHEM BC/BS PIN |
| 201029450 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01069776A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Health | Noblesville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverview Hospital | 1153216627 | 145 |
News Archive
Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation.
Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.
Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.
Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, applauds the new guidelines just released by the American College of Medical Genetics and Genomics, supporting the use of non-invasive prenatal tests (NIPT/NIPS) as an optimal, initial option to screen for specific genetic conditions, such as Trisomy 21 (Down syndrome) during pregnancy.
› Verified 3 days ago
| Entity Name | Riverview Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609074921 PECOS PAC ID: 1153216627 Enrollment ID: O20040216000572 |
News Archive
Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation.
Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.
Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.
Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, applauds the new guidelines just released by the American College of Medical Genetics and Genomics, supporting the use of non-invasive prenatal tests (NIPT/NIPS) as an optimal, initial option to screen for specific genetic conditions, such as Trisomy 21 (Down syndrome) during pregnancy.
› Verified 3 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation.
Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.
Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.
Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, applauds the new guidelines just released by the American College of Medical Genetics and Genomics, supporting the use of non-invasive prenatal tests (NIPT/NIPS) as an optimal, initial option to screen for specific genetic conditions, such as Trisomy 21 (Down syndrome) during pregnancy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manisha Agarwala, MD 250 N Shadeland Ave, Suite 130, Indianapolis, IN 46219-4959 Ph: () - | Dr Manisha Agarwala, MD 11700 N Meridian St, Carmel, IN 46032-4656 Ph: (317) 688-3140 |
News Archive
Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation.
Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.
Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.
Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, applauds the new guidelines just released by the American College of Medical Genetics and Genomics, supporting the use of non-invasive prenatal tests (NIPT/NIPS) as an optimal, initial option to screen for specific genetic conditions, such as Trisomy 21 (Down syndrome) during pregnancy.
› Verified 3 days ago
Dr. Jack K Keene, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11700 N Meridian St, Carmel, IN 46032 Phone: 317-688-3140 Fax: 317-688-2664 | |
Dr. Paula Lange, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3252 Tantara Bnd, Carmel, IN 46032 Phone: 317-733-8252 | |
Dr. Matthew N Negaard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 | |
Sean Tokita, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13500 N Meridian St, Carmel, IN 46032 Phone: 626-354-3195 | |
Dr. Rachel Marie White, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11700 N Meridian St, Carmel, IN 46032 Phone: 317-688-3140 | |
Dr. Rodney Eugene Corson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10921 Lakeview Dr, Carmel, IN 46033 Phone: 317-844-8203 | |
Sean M Trivedi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11700 N Meridian St, Emergency Department, Carmel, IN 46032 Phone: 317-688-3139 Fax: 317-688-2664 |